Patients' Perspectives on Discontinuing Buprenorphine for the Treatment of Opioid Use Disorder.

ABSTRACT:

Objectives

Buprenorphine and other medications for opioid use disorder (OUD) are recommended as standard of care in the treatment of OUD and are associated with positive health and addiction-related outcomes. Despite benefits, discontinuation is common, with half of patients discontinuing in the first year of treatment. Addressing OUD is a major clinical priority, yet little is known about the causes of medication discontinuation from the patient perspective.

Methods

From March 2021 to April 2022, we conducted qualitative interviews with patients who had discontinued buprenorphine for the treatment of OUD within the past 12 months. Eligible participants were selected from 2 Veterans Health Administration Health Care Systems in Oregon. Coding and analysis were guided by conve

SUBMITTER: Wyse JJ 

PROVIDER: S-EPMC11853618 | biostudies-literature | 2024 May-Jun 01

REPOSITORIES: biostudies-literature